Latest filing published 06 Jul 2021 for Regenerx Biopharmaceuticals INC, €13k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -48.3%Entry US$30.00 · Close at T+365 US$15.50
- -21.2%Entry US$179.00 · Close at T+365 US$141.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
J. J. Finkelstein: trading record in brief
This profile gathers the share dealings of J. J. Finkelstein in Regenerx Biopharmaceuticals Inc, where the filings describe the role as chief executive. In total, 11 filings cover trades dated from 22 April 2005 to 30 June 2021.
In open-market terms, that means 5 purchases worth €24k on one side and 1 sale worth €275k on the other. Sales outweigh purchases by €251k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 1 share grant. In 2021 alone, the filings show 1 purchase and no sales.
The median purchase comes to €4,673. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -32.4%. This is a record of the past, not a forecast.
The newest entry dates from 6 July 2021: an open-market purchase of €13k, in Regenerx Biopharmaceuticals Inc. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to J. J. Finkelstein
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 75,000 shares@ US$0.20100.0% of flowCommon StockSEC:0000914190-21-000193:0Canonical exit: 28 Sept 2021 (T+90)
- 104,456 shares@ US$0.06Common StockSEC:0000914190-18-000281:0
- 125,347 shares@ US$0.15Common StockSEC:0000914190-17-000320:0
- 20,000 shares@ US$0.15Common StockSEC:0000914190-17-000320:1
- 900 shares@ US$1.56Common StockSEC:0001181431-07-056408:0Canonical exit: 5 Dec 2007 (T+90)
- 4,100 shares@ US$1.57Common StockSEC:0001181431-07-056408:1Canonical exit: 5 Dec 2007 (T+90)
- 18,000 shares0Common StockSEC:0001181431-06-033681:0
- 6,000 shares0Common StockSEC:0001181431-06-033681:1
- 125,000 shares@ US$2.80Common StockSEC:0001181431-06-033681:2
9 of 9 declarations